BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30

BGM Group Ltd.

Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jul 21, 2026

$8.97+0.32 (+3.70%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

BGM Group Ltd. income statement

AnnualQuarterlyTTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-09-30	FY 2024 2024-09-30	FY 2023 2023-09-30	FY 2022 2022-09-30	FY 2021 2021-09-30	FY 2020 2020-09-30	FY 2019 2019-09-30	FY 2018 2018-09-30
Revenue	38	25	46	65	57	50	46	50
Cost of Revenue	32	21	45	59	51	42	36	42
Gross Profit	6.31	4.11	1.75	6.23	5.64	7.54	9.68	8.13
Research & Development	0.67	1.36	0.57	1.22	0.01	0.05	0.04	–
Selling, General & Admin	18	3.32	3.79	4.13	3.25	2.73	3.50	2.16
General & Administrative	17	2.72	2.83	2.15	2.26	–	–	–
Advertising Expenses	–	0.09	0.15	0.17	0.12	0.00	–	–
Operating Income	-13	-0.56	-2.61	2.10	2.39	4.81	6.18	5.97
Interest Expense	–	–	–	–	0.06	0.24	0.22	0.22
Income from Equity Investments	–	0.16	0.21	0.21	0.19	0.11	0.08	–
Other Non-Operating Income	-7.36	-1.57	-5.29	-0.54	0.98	0.99	0.76	0.17
Asset Impairment Charges	–	0	0	0	0	–	–	–
Gain (Loss) on Sale of Assets	0.00	0.00	–	-0.01	–	–	–	0.00
Pretax Income	-20	-2.14	-7.90	1.56	3.36	5.81	6.94	6.15
Income Tax Expense	0.28	-0.62	0.22	0.19	0.26	0.86	1.03	0.94
Income from Continuing Operations	–	–	–	–	3.15	5.06	5.33	5.17
Net Income incl. Noncontrolling Interests	-20	-1.52	-8.12	1.37	3.11	4.94	5.91	5.20
Minority Interest in Earnings	-0.27	-0.07	-0.34	0.29	-0.04	-0.12	0.58	0.03
Net Income	-20	-1.44	-7.78	1.08	3.15	5.06	5.91	5.20
Net Income to Common	-20	-1.44	-7.78	1.08	–	–	–	–
EPS (Basic)(per share)	-0.18	-0.20	-1.08	0.15	0.45	0.85	0.90	0.85
EPS (Diluted)(per share)	-0.18	-0.20	-1.08	0.15	0.45	0.85	0.90	0.85
Shares Outstanding (Basic, Weighted)(shares)	113	7.23	7.23	7.23	6.82	6.00	6.00	6.00
Shares Outstanding (Diluted, Weighted)(shares)	113	7.23	7.23	7.23	6.82	6.00	6.00	6.00
EBITDA	-11	0.67	-1.47	3.33	3.59	5.92	7.37	7.23
Net Interest Income	–	–	0.10	0.02	-0.06	-0.24	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Sep 30, 2025

Profitability, FY2025

Gross margin: 16.6%
Operating margin: -33.2%
Net margin: -52.6%
Return on equity, FY2025: -9.2%

Financial strength

Current ratio: 1.24
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 23.6%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –